Henrik E. Poulsen
Henrik E. Poulsen
Professor Klinisk Farmakologi
Bekræftet mail på rh.dk
Citeret af
Citeret af
Cancer risk and oxidative DNA damage in man
S Loft, HE Poulsen
Journal of molecular medicine 74, 297-312, 1996
Risk of bleeding with single, dual, or triple therapy with warfarin, aspirin, and clopidogrel in patients with atrial fibrillation
ML Hansen, R Sørensen, MT Clausen, ML Fog-Petersen, J Raunsø, ...
Archives of internal medicine 170 (16), 1433-1441, 2010
The effect of polyphenols in olive oil on heart disease risk factors: a randomized trial
MI Covas, K Nyyssönen, HE Poulsen, J Kaikkonen, HJF Zunft, ...
Annals of internal medicine 145 (5), 333-341, 2006
Oxidative DNA damage estimated by 8-hydroxydeoxyguanosine excretion in humans: influence of smoking, gender and body mass index
S Loft, K Vistisen, M Ewertz, A Tjønneland, K Overvad, HE Poulsen
Carcinogenesis 13 (12), 2241-2247, 1992
Clinical relevance of biomarkers of oxidative stress
J Frijhoff, PG Winyard, N Zarkovic, SS Davies, R Stocker, D Cheng, ...
Antioxidants & redox signaling 23 (14), 1144-1170, 2015
Olive oil and health: summary of the II international conference on olive oil and health consensus report, Jaén and Córdoba (Spain) 2008
J López-Miranda, F Pérez-Jiménez, E Ros, R De Caterina, L Badimón, ...
Nutrition, metabolism and cardiovascular diseases 20 (4), 284-294, 2010
Role of oxidative DNA damage in cancer initiation and promotion
HE Poulsen, H Prieme, S Loft
European journal of cancer prevention, 9-16, 1998
Establishing the background level of base oxidation in human lymphocyte DNA: results of an interlaboratory validation study
CM Gedik, A Collins, J Dubois, P Duez, L Kouegnigan, JF Rees, S Loft, ...
Faseb Journal 19 (1), 82-84, 2005
Fluvoxamine is a potent inhibitor of cytochrome P4501A2
K Brøsen, E Skjelbo, BB Rasmussen, HE Poulsen, S Loft
Biochemical pharmacology 45 (6), 1211-1214, 1993
Six-year effect of combined vitamin C and E supplementation on atherosclerotic progression: the Antioxidant Supplementation in Atherosclerosis Prevention (ASAP) Study
RM Salonen, K Nyyssönen, J Kaikkonen, E Porkkala-Sarataho, ...
Circulation 107 (7), 947-953, 2003
Antioxidant Supplementation in Atherosclerosis Prevention (ASAP) study: a randomized trial of the effect of vitamins E and C on 3‐year progression of carotid atherosclerosis
JT Salonen, K Nyyssönen, R Salonen, HM Lakka, J Kaikkonen, ...
Journal of internal medicine 248 (5), 377-386, 2000
HR Griffiths, L Møller, G Bartosz, A Bast, C Bertoni-Freddari, A Collins, ...
Molecular aspects of medicine 23 (1-3), 101-208, 2002
Dose-dependent inhibition of CYP1A2, CYP2C19 and CYP2D6 by citalopram, fluoxetine, fluvoxamine and paroxetine
U Jeppesen, LF Gram, K Vistisen, S Loft, HE Poulsen, K Brøsen
European journal of clinical pharmacology 51, 73-78, 1996
Are we sure we know how to measure 8-oxo-7, 8-dihydroguanine in DNA from human cells?
AR Collins, J Cadet, L Mőller, HE Poulsen, J Vina
Archives of Biochemistry and Biophysics 423 (1), 57-65, 2004
Increased mortality and cardiovascular morbidity associated with use of nonsteroidal anti-inflammatory drugs in chronic heart failure
GH Gislason, JN Rasmussen, SZ Abildstrom, TK Schramm, ML Hansen, ...
Archives of internal medicine 169 (2), 141-149, 2009
Occurrence of Hypermutable Pseudomonas aeruginosa in Cystic Fibrosis Patients Is Associated with the Oxidative Stress Caused by Chronic Lung Inflammation
O Ciofu, B Riis, T Pressler, HE Poulsen, N Høiby
Antimicrobial agents and chemotherapy 49 (6), 2276-2282, 2005
Oxidative stress
BB Halliwell, HE Poulsen
Cigarette smoke and oxidative stress, 1-4, 2006
8‐Hydroxydeoxyguanosine as a urinary biomarker of oxidative DNA damage
S Loft, A Fischer‐Nielsen, IB Jeding, K Vistisen, HE Poulsen
Journal of Toxicology and Environmental Health, Part A Current Issues 40 (2 …, 1993
Quantification of 8-oxo-guanine and guanine as the nucleobase, nucleoside and deoxynucleoside forms in human urine by high-performance liquid chromatography–electrospray tandem …
A Weimann, D Belling, HE Poulsen
Nucleic acids research 30 (2), e7-e7, 2002
European contribution to the study of ROS: A summary of the findings and prospects for the future from the COST action BM1203 (EU-ROS)
J Egea, I Fabregat, YM Frapart, P Ghezzi, A Görlach, T Kietzmann, ...
Redox biology 13, 94-162, 2017
Systemet kan ikke foretage handlingen nu. Prøv igen senere.
Artikler 1–20